Last year, we talked about a new cancer “vaccine” currently in clinical trials in an article here, and now a second cancer vaccine is capturing media interest due to impressive results in the lab. The new therapy is now in human clinical trials for lymphoma patients.
Researchers at Stanford Medicine have found that injecting two immune system stimulating agents directly into a solid tumor can eradicate the tumor completely. The treatment is also able to destroy distant metastases that have not been directly treated themselves.
Read more
Comments are closed.